Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,027,744
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
20,244,521
-
Shares change
-
+44,782
-
Total reported value, excl. options
-
$434,046,210
-
Value change
-
-$4,189,870
-
Put/Call ratio
-
298%
-
Number of buys
-
61
-
Number of sells
-
30
-
Price
-
$21.44
Institutional Holders of NextCure, Inc. - Common Stock (NXTC) as of Q2 2020
As of 30 Jun 2020 NextCure, Inc. - Common Stock (NXTC) had 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 20,244,521 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, Sofinnova Investments, Inc., Canaan Partners X LLC, LORD, ABBETT & CO. LLC, ALLIANCEBERNSTEIN L.P., BlackRock Inc., GREAT POINT PARTNERS LLC, ArrowMark Colorado Holdings LLC, Cormorant Asset Management, LP, and VANGUARD GROUP INC.
This table shows 87 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.